Moleculin Biotech, Inc. is preclinical and clinical-stage pharmaceutical company focused on the development of game-changing anti-cancer drug candidates, many of which are based on discoveries made at M.D. Anderson Cancer Center. Each of our projects represents a breakthrough discovery and a highly disruptive technology.

IR Calendar

Upcoming Events

There are no upcoming events scheduled at this time. Sign up here to receive notices about upcoming events and press releases.

Past Events

Conference Call to Discuss FDA Filing and New Immune Checkpoint Data

Dec 12, 2018 • 4:30pm EST

Webcast

Participants can dial (800) 860-2442 or (412) 858-4600 to access the conference call.

A teleconference replay will be available at (877) 344-7529 or (412) 317-0088, confirmation code 10126965, through December 19, 2018.

More past events »